The global vertebroplasty and kyphoplasty market was valued at $757.1 million in 2021, and is projected to reach $1,308.1 million by 2031, registering a CAGR of 5.6% from 2022 to 2031. Vertebroplasty and kyphoplasty are minimally invasive surgical techniques, used for the treatment of vertebral compression factures in the spinal cord. Vertebroplasty is a technique, which includes the injection of special cement into the fractured vertebra that provides relief from spinal pain and helps restore the mobility of body. In vertebroplasty, bone cement, also named as polymethyl-methacrylate, is injected through the hollow needle into the fractured bone. On the other hand, kyphoplasty also involves the injection of special cement into the patients’ vertebrae, but with an additional step by creating space for the treatment with a balloon-like device, which is also known as balloon kyphoplasty. In addition, kyphoplasty is recommended for the treatment of cancer-damaged vertebrae and other spinal fractures. These surgical procedures are used to stop the pain caused by a spinal fracture, to stabilize the bone and to restore the loss of vertebral body height due to the compression fracture.
Rise in number of vertebral column factures is the major driving factor for the growth of the market. According to the data published by American Academy of Orthopedic Surgeons in November 2021, there are an estimated 1.5 million vertebral column fracture cases each year in the U. S. This condition mainly occurs due to osteoporosis and traumas like falls, sports injuries or car accidents, and others. Although, the condition can be treated through therapies and by wearing braces for few months, but severe spinal fractures need to be treated through surgical procedure. Furthermore, vertebroplasty and kyphoplasty techniques are
severe fractures. Rise in incidence of vertebral column fractures further demands for treatment procedures such as vertebroplasty and kyphoplasty, thus, propelling the growth of the market.
In addition, rise in advancements in the healthcare sector is also driving the market growth. For instance, the development of OsseoFlex System, which includes an expandable titanium mesh cage, is used in the treatment of osteoporotic vertebral fractures (OVCFs). This technique is used to prevent kyphotic deformity by compacting the surrounding trabecular bone. Further, the height of the fractured vertebra is restored by injection of special cement and by the compaction of the trabecular bone by the titanium mesh cage. In addition, less cement is required in such technique than that of the percutaneous kyphoplasty. Thus, more such advancements in the field of vertebroplasty and kyphoplasty augment the growth of the market during the forecast period.
Also, rise in adoption of minimally invasive surgeries around the globe, is driving the market growth. As vertebroplasty and kyphoplasty are well-known minimally invasive surgery techniques, nowadays there is witnessed rise in their adoption for the treatment of vertebral compression fractures. The advantages offered by minimally invasive surgeries, such as less pain, faster recovery after an operation, earlier return to work, and better results are leading to rise in adoption of this technique by the healthcare provider and also the patients, which further leads to the expansion of the market.
Furthermore, factors such as increase in geriatric population, rise in incidence of vertebral fractures, growing healthcare facilities, increase in demand for technically advanced products, presence of major market manufacturers along with rising technological advancements in vertebroplasty and kyphoplasty, and increasing developments in the medical devices industry are driving the growth of the vertebroplasty and kyphoplasty market. Although many factors are diving the growth of the market, the high cost related to these advanced
surgical techniques along with minor risk associated with these surgeries is causing hindrance to the growth of the market. In addition, the major opportunities available for the vertebroplasty and kyphoplasty market include medical tourism due to high cost of surgeries, growth opportunity in emerging markets, and technological advancement in product associated with the management of vertebral fractures.
The vertebroplasty and kyphoplasty market is studied on the basis of product, end user, and region. By product, the market is segmented into kyphoplasty and vertebroplasty. By end user, it is classified into hospitals and ambulatory surgical centers. Region-wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include, BPB Medica - Biopsybell, Johnson & Johnson (DePuy Synthes), Globus Medical Inc., Halma plc. (IZI Medical Products), Joimax GmbH, Medtronic plc., Merit Medical Systems Inc., Seawon Meditech, Stryker Corporation, and Zavation.
Rise in number of vertebral column factures is the major driving factor for the growth of the market. According to the data published by American Academy of Orthopedic Surgeons in November 2021, there are an estimated 1.5 million vertebral column fracture cases each year in the U. S. This condition mainly occurs due to osteoporosis and traumas like falls, sports injuries or car accidents, and others. Although, the condition can be treated through therapies and by wearing braces for few months, but severe spinal fractures need to be treated through surgical procedure. Furthermore, vertebroplasty and kyphoplasty techniques are
severe fractures. Rise in incidence of vertebral column fractures further demands for treatment procedures such as vertebroplasty and kyphoplasty, thus, propelling the growth of the market.
In addition, rise in advancements in the healthcare sector is also driving the market growth. For instance, the development of OsseoFlex System, which includes an expandable titanium mesh cage, is used in the treatment of osteoporotic vertebral fractures (OVCFs). This technique is used to prevent kyphotic deformity by compacting the surrounding trabecular bone. Further, the height of the fractured vertebra is restored by injection of special cement and by the compaction of the trabecular bone by the titanium mesh cage. In addition, less cement is required in such technique than that of the percutaneous kyphoplasty. Thus, more such advancements in the field of vertebroplasty and kyphoplasty augment the growth of the market during the forecast period.
Also, rise in adoption of minimally invasive surgeries around the globe, is driving the market growth. As vertebroplasty and kyphoplasty are well-known minimally invasive surgery techniques, nowadays there is witnessed rise in their adoption for the treatment of vertebral compression fractures. The advantages offered by minimally invasive surgeries, such as less pain, faster recovery after an operation, earlier return to work, and better results are leading to rise in adoption of this technique by the healthcare provider and also the patients, which further leads to the expansion of the market.
Furthermore, factors such as increase in geriatric population, rise in incidence of vertebral fractures, growing healthcare facilities, increase in demand for technically advanced products, presence of major market manufacturers along with rising technological advancements in vertebroplasty and kyphoplasty, and increasing developments in the medical devices industry are driving the growth of the vertebroplasty and kyphoplasty market. Although many factors are diving the growth of the market, the high cost related to these advanced
surgical techniques along with minor risk associated with these surgeries is causing hindrance to the growth of the market. In addition, the major opportunities available for the vertebroplasty and kyphoplasty market include medical tourism due to high cost of surgeries, growth opportunity in emerging markets, and technological advancement in product associated with the management of vertebral fractures.
The vertebroplasty and kyphoplasty market is studied on the basis of product, end user, and region. By product, the market is segmented into kyphoplasty and vertebroplasty. By end user, it is classified into hospitals and ambulatory surgical centers. Region-wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include, BPB Medica - Biopsybell, Johnson & Johnson (DePuy Synthes), Globus Medical Inc., Halma plc. (IZI Medical Products), Joimax GmbH, Medtronic plc., Merit Medical Systems Inc., Seawon Meditech, Stryker Corporation, and Zavation.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vertebroplasty and kyphoplasty market analysis from 2021 to 2031 to identify the prevailing vertebroplasty and kyphoplasty market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the vertebroplasty and kyphoplasty market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global vertebroplasty and kyphoplasty market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Kyphoplasty
- Vertebroplasty
By End User
- Hospitals
- Ambulatory Surgical Centers
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Johnson and Johnson (DePuy Synthes)
- Medtronic plc
- Globus Medical Inc
- Halma plc
- Zavation LLC
- BPB MEDICA - BIOPSYBELL
- Merit Medical Systems Inc.
- Seawon Meditech
- Joimax GmbH
- Stryker Corporation
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Kyphoplasty
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Vertebroplasty
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Ambulatory Surgical Centers
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U. S.
6.2.4.1.1 Key market trends, growth factors and opportunities
6.2.4.1.2 Market size and forecast, by Product
6.2.4.1.3 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Key market trends, growth factors and opportunities
6.2.4.2.2 Market size and forecast, by Product
6.2.4.2.3 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Key market trends, growth factors and opportunities
6.2.4.3.2 Market size and forecast, by Product
6.2.4.3.3 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Key market trends, growth factors and opportunities
6.3.4.1.2 Market size and forecast, by Product
6.3.4.1.3 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Key market trends, growth factors and opportunities
6.3.4.2.2 Market size and forecast, by Product
6.3.4.2.3 Market size and forecast, by End User
6.3.4.3 UK
6.3.4.3.1 Key market trends, growth factors and opportunities
6.3.4.3.2 Market size and forecast, by Product
6.3.4.3.3 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Key market trends, growth factors and opportunities
6.3.4.4.2 Market size and forecast, by Product
6.3.4.4.3 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Key market trends, growth factors and opportunities
6.3.4.5.2 Market size and forecast, by Product
6.3.4.5.3 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Key market trends, growth factors and opportunities
6.3.4.6.2 Market size and forecast, by Product
6.3.4.6.3 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Key market trends, growth factors and opportunities
6.4.4.1.2 Market size and forecast, by Product
6.4.4.1.3 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Key market trends, growth factors and opportunities
6.4.4.2.2 Market size and forecast, by Product
6.4.4.2.3 Market size and forecast, by End User
6.4.4.3 India
6.4.4.3.1 Key market trends, growth factors and opportunities
6.4.4.3.2 Market size and forecast, by Product
6.4.4.3.3 Market size and forecast, by End User
6.4.4.4 Australia
6.4.4.4.1 Key market trends, growth factors and opportunities
6.4.4.4.2 Market size and forecast, by Product
6.4.4.4.3 Market size and forecast, by End User
6.4.4.5 South Korea
6.4.4.5.1 Key market trends, growth factors and opportunities
6.4.4.5.2 Market size and forecast, by Product
6.4.4.5.3 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Key market trends, growth factors and opportunities
6.4.4.6.2 Market size and forecast, by Product
6.4.4.6.3 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Key market trends, growth factors and opportunities
6.5.4.1.2 Market size and forecast, by Product
6.5.4.1.3 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Key market trends, growth factors and opportunities
6.5.4.2.2 Market size and forecast, by Product
6.5.4.2.3 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Key market trends, growth factors and opportunities
6.5.4.3.2 Market size and forecast, by Product
6.5.4.3.3 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Key market trends, growth factors and opportunities
6.5.4.4.2 Market size and forecast, by Product
6.5.4.4.3 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Players
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Johnson and Johnson (DePuy Synthes)
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Medtronic plc
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Globus Medical Inc
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Halma plc
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Zavation LLC
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 BPB MEDICA - BIOPSYBELL
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Merit Medical Systems Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Seawon Meditech
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Joimax GmbH
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Stryker Corporation
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Vertebroplasty and Kyphoplasty Market,' the vertebroplasty and kyphoplasty market was valued at $757.10 million in 2021, and is estimated to reach $1,308.1 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031.Vertebroplasty and Kyphoplasty Market likely to experience significant growth rate of 5.6% from 2022-2031 owing to increasing market demand for vertebroplasty and kyphoplasty devices from healthcare sector.
Vertebroplasty and kyphoplasty are the minimally invasive surgeries used to treat spinal conditions. These are the emerging techniques used for the treatment of pain caused by vertebral body compression fractures. Vertebroplasty and kyphoplasty are somewhat similar techniques, but kyphoplasty additionally includes a balloon, which is first inflated in the vertebral body to create a cavity, into which cement is then injected under lower pressure.
Key factors driving the growth of the vertebroplasty and kyphoplasty market include, rise in adoption of minimally invasive spinal procedures, increase in prevalence of spinal disorders, and increase in geriatric population, who are more prone to spinal disorders. In addition, rise in awareness among the population regarding the vertebroplasty and kyphoplasty and its related advantages drives the growth of the market. Furthermore, awareness about advanced treatment options provided by hospitals and high preference of patients for hospitals due to the availability support provided for vertebral compression fractures are expected to augment the growth of the vertebroplasty and kyphoplasty market.
In addition, the strategies adopted by the key market players offer lucrative opportunities to the market growth. Key market players are adopting various strategies to expand their businesses in the healthcare sector, which also helps to enhance the vertebroplasty and kyphoplasty product portfolio of the company. For instance, strategies adopted by the companies include, partnership, product launch, product approval, and acquisition, which further increases the manufacturing and distributing capacity of the market players. Thus, adoption of such strategies provides lucrative opportunity for the market player for investment and also, provides growth opportunities in the market during the forecast period.
The vertebroplasty and kyphoplasty market is studied on the basis of product, end user, and region. By product, the market is segmented into kyphoplasty and vertebroplasty. By end user, it is classified into hospitals and ambulatory surgical centers. Region-wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include, BPB Medica - Biopsybell, Johnson & Johnson (DePuy Synthes), Globus Medical Inc., Halma plc. (IZI Medical Products), Joimax GmbH, Medtronic plc., Merit Medical Systems Inc., Seawon Meditech, Stryker Corporation, and Zavation. The players in the market have been actively engaged in the adoption various strategies, such as acquisition, product launch, product approval, partnership and clinical trials to remain competitive and gain advantage over the competitors in the market. For instance, in August 2021, Halma (IZI Medical Products) announced launch of Vertefix HV Bone Cement, for vertebroplasty and kyphoplasty procedures with insite tracking beads for real-time flow visualization, with high viscosity and long working time.
Key Market Insights
- By product, the kyphoplasty segment was the highest revenue contributor to the market in2021 and is expected to be the fastest-growing segment with a CAGR of 5.9% during the forecast period.
- By end user, the hospitals segment was the highest revenue contributor to the market in 2021, and is expected to grow with a CAGR of 5.4% during the forecast period.
- Region-wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Johnson and Johnson (Depuy Synthes)
- Medtronic PLC
- Globus Medical Inc.
- Halma PLC
- Zavation LLC
- Bpb Medica - Biopsybell
- Merit Medical Systems Inc.
- Seawon Meditech
- Joimax GmbH
- Stryker Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 183 |
| Published | November 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 757.1 million |
| Forecasted Market Value ( USD | $ 1308.1 million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
